Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Clinical trial NCT00483548 · COMPLETED

Trial details

NCT number: NCT00483548
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Depression, Bipolar

Start date: 2007-10-01
Primary completion: 2008-12-01
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.